AMGN

7 Biotechnology Stocks to Buy Now

The grades of seven biotechnology stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More 

4 Ways to Play the Boom in Biotech Stocks

Whether you love risk or hate it, there's a way to invest in red-hot biotech stocks. Here are four options for investors of all different tolerances. More 

7 Biotechnology Stocks to Buy Now

Seven biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More 

7 Biotechnology Stocks to Buy Now

The grades of seven biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. More 

7 Biotechnology Stocks to Buy Now

This week, seven biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More 

7 Biotechnology Stocks to Buy Now

This week, seven biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More 

Among Biotechs, Amgen Stock Offers Dividend Income

Biotech giant AMGN has a nice benefit Amgen stock in that it pays a dividend. With a low payout ratio, investors should look for increases in the future. More